Abstract
Introduction
The frequency of aneuploidies in human oocytes is very high and up to 60% of them have been reported to be chromosomally abnormal [1] . The incidence in humans seems to be much higher than in other mammals: mouse -approximately 5%, cattle -10%, pig -10% [2] . It must be, however, emphasized that these estimations often differ, depending on the technique used. The reason why human oocytes are so often chromosomally abnormal remains undiscovered. In fact, the basis for aneuploidies can be established long before they can be detected in fully grown oocytes [3] . Hunt and Hassold [3] defined three developmental phases of oogenesis when the quality of oocytes can be influenced -i/ oogenesis, ii/ follicle formation and iii/ oocyte growth and maturation. The research in this field in humans is mostly oriented towards the final phase of the oocyte development: its maturation covering the period when the oocyte undergoes germinal vesicle breakdown and subsequently reaches the metaphase II stage [4] . Highly dynamic morphological changes and specific histone modifications were reported to occur in mammalian oocytes within that time period. An immature oocyte contains a prominent nucleus (germinal vesicle -GV), in which a well-visible nucleolus can be seen in some species (rodents, humans, pig). A germinal vesicle breakdown (GVBD), in other words the dissolution of GV membrane, disappearance of nucleoli and gradual condensation of chromatin, occurs following a gonadotropin surge or in in vitro cultures. The condensed chromosomes are then arranged in the metaphase I stage (MI) with a well-formed spindle. This stage is followed by a short anaphase to telophase I (A-TI) transition, during which a half of the oocyte chromosome complement is extruded from the oocyte in the form of the first polar body (PBI). The chromosomes are again arranged on a metaphase plate (metaphase II, MII).
In most mammals, the oocyte is released from the follicle at that stage and then fertilized by the sperm. The histone modifications studies are mostly focused on acetylation and methylation, while the most exhaustive experiments were performed in mice. Methylation of chromatin has been reported to be rather constant and positive labeling was detected not only on condensed chromosomes (MI, A-TI, MII), but also in the nuclei [5, 6] . Quite different situation was, however, observed when antibodies against acetylated histones were used. In general, germinal vesicles were consistently positively labeled but as soon as chromosomes condensed (MI, MII), no labeling was detected. The only exception is the anaphase to telophase I (A-TI) transition with a weak signal on chromosomes [7, 8, 9, 10] . It must be noted, however, that a different pattern of labeling was detected in pigs, where chromatin remained acetylated [11] .
Interestingly, the oocyte chromosome acetylation has been shown to increase with age of the female and also some IVF (in vitro fertilization) techniques may be the influencing factor [12, 13, 14] . A clear association between the aberrant acetylation pattern and the unequal segregation of chromosomes has been demonstrated in mice [15, 16] . Whilst in oocytes isolated from young females no positive labeling was detected on condensed chromosomes, in oocytes from old females about half of the metaphases showed a positive signal. The increased acetylation of chromosomes was also detected in oocytes aged in culture (MII). Thus, it is logical to assume that similar situation may exist in humans, too. As mentioned above, human oocytes are often chromosomally abnormal and thus one can expect that the analysis of chromosome acetylation pattern will correlate with aneuploidies. To the best of our knowledge, only two papers on the acetylation in human oocytes were published after the completion of our study [17, 18] . We analyzed the pattern of acetylation in spare human oocytes, i.e. those that did not reach the metaphase II stage at the time of their aspiration from the follicles or eventually remained unfertilized after IVF.
Material and methods
Human oocytes, after standard stimulation, were collected by aspiration from follicles and immediately morphologically evaluated. Written consent was obtained from all couples and the study was approved by the Ethical Board of GENNET. In total, we analyzed 311 oocytes obtained from 152 patients, aged from 26 to 38 years, treated at GENNET for a wide range of infertility problems (endometriosis, tubal factors, PCOS -polycystic ovarian syndrome, anovulation, genetic factors, male factors, etc.). The mature oocytes, i.e. the metaphase II staged, were used either for ICSI or were mixed with spermatozoa. The remaining oocytes were briefly cultured (2-3h) in Quinns Advantage Protein Plus Cleavage Medium (SAGE IVF, Trumbull, CT, USA) at 37 o C and 5% CO 2; during that period some oocytes expelled first polar bodies. Thereafter, zonae pellucidae were dissolved by pronase (0.5%) in PBS (phosphate buffered saline) and then the oocytes were fixed with 4% paraformaldehyde (PFA) in PBS for 30min. The oocytes were then kept in PBS at 4°C until immunolabeling. Before labeling the oocytes were permeabilized by Triton X-100 (0.2% in PBS) for 10min and then blocked overnight in PBS supplemented with 1% BSA (bovine serum albumin) and 0.1% TritonX-100 at 4°C. The oocytes were then incubated overnight with one of the following antibodies: anti-acetylated H4/K12 (1:800, Upstate) and anti-hyperacetylated H4 (1:1000, Upstate). These antibodies were extensively characterized in our laboratory [5] or were most widely used in studies analyzing the acetylation/deacetylation processes during oocyte maturation in different mammals (anti-acetylated H4/K12). Following the incubation with one of the above mentioned antibodies, the oocytes were washed several times in PBS/BSA and then incubated for 2h 
Control animal oocytes
In order to exclude some technical problems in labeling, we used bovine and mouse oocytes at different stages of maturation as controls. Bovine oocytes were aspirated from large antral follicles and either fixed immediately (GV stage) or cultured in M199 supplemented with FCS (fetal calf serum, 10%), gentamicin (50µg/ml), Na-pyruvate (0.2 mM) and Pergonal (0.1 IU/ml, Serono, UK) for 18-20h at 38.5 o C/5% C0 2 in the air (maturing -MI, mature -MII) and then fixed. Mouse oocytes were isolated from ovaries of PMSG (pregnant mare serum gonadotropin, 5 I.U.) stimulated mice (BDF1) and either fixed immediately (GV) or matured in MEM supplemented with BSA (4mg/ml), gentamicin (50 µg/ml) and Na-pyruvate (0.2 mM) at 37 o / 5% C0 2 in the air for up to 12h and then fixed. The oocytes of both species were treated and labeled similarly as described above for the human oocytes. As the animal oocytes can be easily distinguished from the human oocytes, they were often incubated in the same well.
Results
The results are summarized in Table I . It must be noted that we analyzed only the oocytes with no signs of degeneration, i.e. round-shaped with homogeneous cytoplasm.
First, we tested the antibody that was specific for AcH4/K12. Controls, i.e. bovine (25) and mouse (42) GV staged oocytes were always positively labeled, whereas in human oocytes 90% (95/105) of the immature oocytes showed positive labeling (Fig  1 a,b) . No labeling at all was detected in the remaining ones. 47% of maturing MI stage oocytes were positively labeled (27/58), all telophase I (TI) were positive (Figure 2 a,b) , and 49% (22/45) of the metaphase II oocytes showed a positive signal. Bovine and mouse maturing and mature oocytes showed mostly no labeling (90%).
Anti-hyperacetylated H4 was used as the second antibody. In that case, almost all human immature GV staged oocytes were positively labeled (95%; 35/37). About half of the metaphase I (48%; 40/83) and the metaphase II (50%; 9/18) was positive when this antibody was used, whilst the other half was without labeling. All telophase I stage oocytes were positively labeled.
The expected pattern of labeling was detected in controls, i.e. in bovine and murine oocytes. Here, all GV-staged oocytes were positively labeled (bovine -15, murine -25), in maturing oocytes no labeling was detected in almost all oocytes (45 -bovine, 56 -murine). Surprisingly, we found evident differences in labeling when comparing the pattern of labeling (AcH4/K12, anti-hyperacetylated H4) between oocytes obtained from the younger and the older patients, (under and over the age of 30, respectively). Similarly, we were unable to find any relationship between the pattern of labeling and a given fertility problem.
In conclusion, when compared to other species tested so far, our results demonstrate that the analysis of acetylation/deacetylation of chromatin in human oocytes gave us rather inconsistent results . At present, it would be very difficult to use this labeling to evaluate the quality of oocytes and to explain the high frequency of aneuploidies in them.
Discussion
The ovary contains basically three categories of oocytes: growing, intermediate and full-grown. Only full-grown oocytes can undergo germinal vesicle breakdown and reach the metaphase II stage [4] . This, however, does not mean that they are chromosomally normal and developmentally fully competent. For example, it has been convincingly demonstrated that those oocytes where the nucleolus is surrounded with a ring of chromatin are the best ones.
In general, GV (immature) oocytes of all mammalian species labeled so far with antibodies against acetylated histones were positive [19, 20, 21] , but the use of these antibodies (anti-AcH4/ K12, anti-hyperacetylated H4) also indicates that the extrapolation of the results obtained in laboratory and domestic animals to humans, in order to explain the frequency of aneuploidies, may be risky. Essentially, our results are in agreement with the observations of van der Berg et al. [18] , who found that all immature oocytes (GV) labeled with anti-AcH4/K12 antibody and approximately 50% of MI and MII oocytes were positive. Moreover, detailed analyses demonstrate a positive correlation between positive labeling and abnormal spindle morphology. This may consequently lead to unequal distribution of the chromosomal material, either during the exit from the metaphase I or the metaphase II. Their results, however, also show that it will be difficult to find any relationship between the acetylation pattern and aberrant chromosome segregation. AcH4K12 seems to be the most convenient of all antibodies they tested (AcH4K5, AcH4K8, AcH4K12, AcH4K16). These authors also found certain differences in labeling (AcH4/K12) between the oocytes and NSN (non-surrounded nucleolus) oocytes. As no differences between these two groups were detected, the data were pooled.
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from the young vs. the older patients. The first group contained fewer oocytes that were positively labeled with that antibody. We did not find these differences in our study. That, however, may be explained by different media that had been used for oocyte culture before they were fixed [22] . Slightly different results were reported by Huang et al. [17] , who noted positive labeling for all GV-staged oocytes (AcH4K12, AcH3K9). For AcH3K9 the percentage of positively labeled maturing and mature oocytes was below 50% in in vitro matured oocytes and almost all in vivo matured ones were without labeling. Essentially, the same situation was observed when AcH4K12 antibody was used. The explanation for these differences is very difficult and one cannot exclude that certain technical aspects, i.e. the oocyte culture, handling and labeling, might have influenced the overall pattern of labeling.
In general, the interpretation of our results poses considerable challenges. First, it must be noted that we used oocytes from patients with different fertility problems. Second, we analyzed only those oocytes that did not reach the MII stage at the time of their collection from follicles. The question remains whether these oocytes are somewhat abnormal when compared to more rapidly maturing oocytes. It has been clearly demonstrated that oocytes maturing faster are, after fertilization, developmentally more competent than those oocytes in which maturation lasts longer [23] . It has been also shown that certain manipulations and culture conditions influence the level of methylation (global DNA methylation and/or histone acetylation) in embryos [20, 24, 14] . Essentially, the labeling intensity in manipulated embryos was significantly higher than in controls. Manosalva and Gonzales [25] demonstrated in mice that the consistency of labeling decreases in GV stage oocytes with an increasing female age.
We hypothesize that there may be two possible explanations: a) human oocytes are distinct when compared to other mammalian species tested so far, b) the prevailing population of human oocytes is abnormal.
It is fairy difficult to determine these issues as human oocytes are primarily used for test tube babies production and spare, high quality oocytes, are available only in exceptional situations.
Clearly, more detailed analysis in this field is necessary to account for the high frequency of aneuploidies in human oocytes and embryos, as well as to develop some ways of their prevention [26, 27] . 
